Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
17.21
-0.97 (-5.36%)
Sep 23, 2026, 10:58 AM EDT - Market open
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.54 billion as of September 23, 2026. Its market cap has increased by 19.81% in one year.
Market Cap
1.54B
Enterprise Value
1.57B
1-Year Change
19.81%
Ranking
Category
Stock Price
$17.21
ChartMarket Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.54B, an increase of 636.72%. That is a compound annual growth rate of 20.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.54B | -15.84% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kailera Therapeutics | 1.66B |
| Absci | 1.66B |
| Immunocore Holdings | 1.65B |
| Taysha Gene Therapies | 1.64B |
| AnaptysBio | 1.63B |
| Inhibrx Biosciences | 1.61B |
| Korsana Biosciences | 1.59B |
| Kardigan | 1.56B |